Details of the Drug
General Information of Drug (ID: DM31YVO)
| Drug Name |
Glecaprevir
|
|||||
|---|---|---|---|---|---|---|
| Synonyms |
Glecaprevir; Glecaprevir (USAN/INN); Glecaprevir [USAN]; J3.646.120I; K6BUU8J72P; SB19760; SCHEMBL883097; glecaprevirum; 1365970-03-1; A-1282576.0; ABT 493; ABT-493; ABT-493(Glecaprevir); CHEMBL3545363; CS-8098; D10814; DB13879; EX-A1940; HY-17634; UNII-K6BUU8J72P
|
|||||
| Affected Organisms |
Hepatitis C Virus
|
|||||
| Structure |
![]() |
|||||
| 3D MOL is unavailable | 2D MOL | |||||
| #Ro5 Violations (Lipinski): 2 | Molecular Weight (mw) | 838.9 | ||||
| Logarithm of the Partition Coefficient (xlogp) | 4.6 | |||||
| Rotatable Bond Count (rotbonds) | 7 | |||||
| Hydrogen Bond Donor Count (hbonddonor) | 3 | |||||
| Hydrogen Bond Acceptor Count (hbondacc) | 15 | |||||
| Chemical Identifiers |
|
|||||
| Cross-matching ID | ||||||
| Drug ADMET Endpoint Profile (DAE)NEW | Click to Jump to the Detailed DAE Information of This Drug | |||||
Molecular Interaction Atlas of This Drug
![]() Drug Transporter (DTP) |
|
||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
![]() Drug-Metabolizing Enzyme (DME) |
|
||||||||||||||||||||
| Molecular Interaction Atlas (MIA) | |||||||||||||||||||||



